Neuropsychiatric changes precede classic motor symptoms in ALS and do not affect survival

Neurology

Volumn 82, Issue 2, 2014, Pages 149-154

  Mioshi, Eneida ^a   Caga, Jashelle ^a   Lillo, Patricia ^d   Hsieh, Sharpley ^a   Ramsey, Eleanor ^a   Devenney, Emma ^a,b   Hornberger, Michael ^a,b   Hodges, John R ^a,b   Kiernan, Matthew C ^c  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ADDENBROOKE COGNITIVE EXAMINATION REVISED; ADULT; AMYOTROPHIC LATERAL SCLEROSIS; AMYOTROPHIC LATERAL SCLEROSIS FUNCTIONAL RATING SCALE REVISED; ANATOMICAL VARIATION; ARTICLE; BEHAVIOR CHANGE; BRAIN DISEASE; BULBAR ONSET DISEASE; CLASSIC MOTOR SYMPTOM; CLINICAL FEATURE; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DISEASE PREDISPOSITION; FEMALE; FRONTOTEMPORAL DEMENTIA; FUNCTIONAL ASSESSMENT; HUMAN; LIMB ONSET DISEASE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL FUNCTION; MOTOR NEURON DISEASE BEHAVIORAL SCALE; MOTOR PERFORMANCE; NEUROPSYCHIATRIC SYMPTOM; NEUROPSYCHOLOGICAL TEST; PHYSICAL DISABILITY; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; RASCH ANALYSIS; SURVIVAL PREDICTION; SYMPTOM ASSESSMENT; AGED; KAPLAN MEIER METHOD; MIDDLE AGED; MOTOR DYSFUNCTION; NEUROLOGIC EXAMINATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PSYCHOLOGICAL ASPECT; SURVIVAL;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; COGNITION; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MENTAL DISORDERS; MIDDLE AGED; MOVEMENT DISORDERS; NEUROLOGIC EXAMINATION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL; SURVIVAL ANALYSIS;

EID: 84895772785     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000023     Document Type: Article

References (37)

1. Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol 2007;6:994-1003.
2. Abrahams S, Leigh PN, Goldstein LH. Cognitive change in ALS: a prospective study. Neurology 2005;64:1222-1226.
3. Murphy JM, Henry RG, Langmore S, Kramer JH, Miller BL, Lomen-Hoerth C. Continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol 2007;64:530-534.
4. Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 2005;65: 586-590.
5. Renton AE, Majounie E, Waite A, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011;72:257-268.
6. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011;72:245-256.
7. Mioshi E, Lillo P, Yew B, et al. Cortical atrophy in ALS is critically associated with neuropsychiatric and cognitive changes. Neurology 2013;80:1117-1123.
8. Lillo P, Mioshi E, Burrell JR, et al. Changes across the amyotrophic lateral sclerosis-frontotemporal dementia continuum. PLoS One 2012;7:e43993.
9. Grossman AB, Woolley-Levine S, Bradley WG, Miller RG. Detecting neurobehavioral changes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2007;8:56-61.
10. Lillo P, Mioshi E, Zoing MC, Kiernan MC, Hodges JR. How common are behavioural changes in amyotrophic lateral sclerosis? Amyotroph Lateral Scler 2011;12:45-51.
11. Gibbons ZC, Richardson A, Neary D, Snowden JS. Behaviour in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2008;9:67-74.
12. Hu WT, Seelaar H, Josephs KA, et al. Survival profiles of patients with frontotemporal dementia and motor neuron disease. Arch Neurol 2009;66:1359-1364.
13. Gordon PH, Delgadillo D, Piquard A, et al. The range and clinical impact of cognitive impairment in French patients with ALS: a cross-sectional study of neuropsychological test performance. Amyotroph Lateral Scler 2011;12:372-378.
14. Hu WT, Shelnutt M, Wilson A, et al. Behavior matters: cognitive predictors of survival in amyotrophic lateral sclerosis. PLoS One 2013;8:e57584.
15. Olney RK, Murphy J, Forshew D, et al. The effects of executive and behavioral dysfunction on the course of ALS. Neurology 2005;65:1774-1777.
16. Strong MJ, Grace GM, Freedman M, et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2009;10:131-146.
17. Brooks BR, Miller RG, Swash M, Munsat TL; World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-299.
18. Vucic S, Kiernan MC. Abnormalities in cortical and peripheral excitability in flail arm variant amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2007;78: 849-852.
19. Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS Functional Rating Scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999;169:13-21.
20. Mioshi E, Hsieh S, Caga J, et al. A novel tool to detect behavioural symptoms in ALS. Poster presented at the 24th International Symposium on ALS/MND; 2013; Milan.
21. Wear HJ, Wedderburn CJ, Mioshi E, et al. The Cambridge Behavioural Inventory Revised. Dement Neuropsychologia 2008;2:102-107.
22. Lillo P, Savage S, Mioshi E, Kiernan MC, Hodges JR. Amyotrophic lateral sclerosis and frontotemporal dementia: a behavioural and cognitive continuum. Amyotroph Lateral Scler 2012;13:102-109.
23. Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR. The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 2006;21:1078-1085.
24. Linacre M. WINSTEPS & Facets Rasch Software. Available at: www.winsteps.com/index.htm. Accessed May 20, 2013.
25. Bland JM, Altman DG. Cronbach's alpha. BMJ 1997; 314:572.
26. Kiernan MC, Vucic S, Cheah BC, et al. Amyotrophic lateral sclerosis. Lancet 2011;377:942-955.
27. Turner MR, Hardiman O, Benatar M, et al. Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol 2013;12:310-322.
28. Hornberger M, Geng J, Hodges JR. Convergent grey and white matter evidence of orbitofrontal cortex changes related to disinhibition in behavioural variant frontotemporal dementia. Brain 2011;134:2502-2512.
29. Filippini N, Douaud G, Mackay CE, Knight S, Talbot K, Turner MR. Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis. Neurology 2010; 75:1645-1652.
30. Tsujimoto M, Senda J, Ishihara T, et al. Behavioral changes in early ALS correlate with voxel-based morphometry and diffusion tensor imaging. J Neurol Sci 2011;307: 34-40.
31. Chio A, Vignola A, Mastro E, et al. Neurobehavioral symptoms in ALS are negatively related to caregivers' burden and quality of life. Eur J Neurol 2010;17:1298-1303.
32. Lillo P, Mioshi E, Hodges JR. Caregiver burden in amyotrophic lateral sclerosis is more dependent on patients' behavioral changes than physical disability: a comparative study. BMC Neurol 2012;12:156.
33. Mioshi E, McKinnon C, Savage S, O'Connor CM, Hodges JR. Improving burden and coping skills in frontotemporal dementia caregivers: a pilot study. Alzheimer Dis Assoc Disord 2013;27:84-86.
34. Hogden A, Greefield D, Nugus P, Kiernan MC. What influences patient decision-making in amyotrophic lateral sclerosis multidisciplinary care? A study of patient perspectives. Patient Prefer Adherence 2012;6:829-838.
35. Woolley SC, Jonathan SK. Cognitive and behavioral impairment in amyotrophic lateral sclerosis. Phys Med Rehabil Clin N Am 2008;19:607-617, xi.
36. Burrell JR, Kiernan MC, Vucic S, Hodges JR. Motor neuron dysfunction in frontotemporal dementia. Brain 2011; 134:2582-2594.
37. Byrne S, Elamin M, Bede P, et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet Neurol 2012;11:232-240.